Home
About
Overview
Sharing Data
ORCID
Help
History (37)
Urothelial Defects from Targeted Inactivation of Exocyst Sec10 in Mice Cause Ureteropelvic Junction Obstructions.
Distinct mechanisms of modulation of angiotensin II type I receptor gene expression in heart and aorta.
Tissue Inhibitor of Metalloproteinase-2
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California.
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project.
See All 37 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project.
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Ann Emerg Med. 2012 Oct; 60(4):451-7.
View in:
PubMed
subject areas
Clinical Trials, Phase II as Topic
Data Interpretation, Statistical
Early Termination of Clinical Trials
Humans
Interdisciplinary Communication
Randomized Controlled Trials as Topic
Research Design
Sample Size
authors with profiles
Yuko Y. Palesch
Jordan J. Elm